60 related articles for article (PubMed ID: 11059749)
1. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
Zi X; Zhang J; Agarwal R; Pollak M
Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749
[TBL] [Abstract][Full Text] [Related]
2. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
Deep G; Raina K; Singh RP; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Dec; 123(12):2750-8. PubMed ID: 18798272
[TBL] [Abstract][Full Text] [Related]
3. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
Koltai T; Fliegel L
J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864
[TBL] [Abstract][Full Text] [Related]
4. Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance.
Hussain Y; Mirzaei S; Ashrafizadeh M; Zarrabi A; Hushmandi K; Khan H; Daglia M
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33807174
[TBL] [Abstract][Full Text] [Related]
5. The Power of Phytochemicals Combination in Cancer Chemoprevention.
Rizeq B; Gupta I; Ilesanmi J; AlSafran M; Rahman MM; Ouhtit A
J Cancer; 2020; 11(15):4521-4533. PubMed ID: 32489469
[TBL] [Abstract][Full Text] [Related]
6. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.
Mishra S; Verma SS; Rai V; Awasthee N; Chava S; Hui KM; Kumar AP; Challagundla KB; Sethi G; Gupta SC
Cell Mol Life Sci; 2019 May; 76(10):1947-1966. PubMed ID: 30879091
[TBL] [Abstract][Full Text] [Related]
8. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.
Imai-Sumida M; Chiyomaru T; Majid S; Saini S; Nip H; Dahiya R; Tanaka Y; Yamamura S
Oncotarget; 2017 Nov; 8(54):92032-92042. PubMed ID: 29190895
[TBL] [Abstract][Full Text] [Related]
9. A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.
Anestopoulos I; Sfakianos AP; Franco R; Chlichlia K; Panayiotidis MI; Kroll DJ; Pappa A
Molecules; 2016 Dec; 22(1):. PubMed ID: 28042859
[TBL] [Abstract][Full Text] [Related]
10. Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.
Bhatia V; Falzon M
Cancer Lett; 2015 Jul; 362(2):199-207. PubMed ID: 25846868
[TBL] [Abstract][Full Text] [Related]
11. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
12. The strategies to control prostate cancer by chemoprevention approaches.
Ting H; Deep G; Agarwal C; Agarwal R
Mutat Res; 2014 Feb; 760():1-15. PubMed ID: 24389535
[TBL] [Abstract][Full Text] [Related]
13. IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations.
Vazquez-Martin A; Cufí S; Oliveras-Ferraros C; Torres-Garcia VZ; Corominas-Faja B; Cuyàs E; Bonavia R; Visa J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA
Sci Rep; 2013; 3():2560. PubMed ID: 23994953
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.
Deep G; Agarwal R
Curr Cancer Drug Targets; 2013 Jun; 13(5):486-99. PubMed ID: 23617249
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer.
Ting H; Deep G; Agarwal R
AAPS J; 2013 Jul; 15(3):707-16. PubMed ID: 23588585
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicines in prostate cancer: from bench to bedside?
Klempner SJ; Bubley G
Oncologist; 2012; 17(6):830-7. PubMed ID: 22618569
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids: A versatile source of anticancer drugs.
Chahar MK; Sharma N; Dobhal MP; Joshi YC
Pharmacogn Rev; 2011 Jan; 5(9):1-12. PubMed ID: 22096313
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.
Deep G; Agarwal R
Cancer Metastasis Rev; 2010 Sep; 29(3):447-63. PubMed ID: 20714788
[TBL] [Abstract][Full Text] [Related]
19. Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3).
Senthilkumar K; Elumalai P; Arunkumar R; Banudevi S; Gunadharini ND; Sharmila G; Selvakumar K; Arunakaran J
Mol Cell Biochem; 2010 Nov; 344(1-2):173-84. PubMed ID: 20658310
[TBL] [Abstract][Full Text] [Related]
20. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
